Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ferndale IP Council is the intellectual property management and holding entity for the Ferndale Pharma Group, a specialty pharmaceutical organization focused on dermatology and proctology. The company manages the patent and trademark portfolios for a range of established branded products, including topical anesthetics and anti-inflammatory treatments. Its assets support the group's core business in treating anorectal disorders, such as anal fissures and hemorrhoids, as well as various skin conditions. By maintaining and protecting proprietary formulations and delivery technologies, Ferndale IP Council ensures the clinical and commercial longevity of the group's therapeutic offerings. The entity operates in conjunction with other group members, such as Ferndale Healthcare and Eloquest Healthcare, to deliver specialty medical solutions to the healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ferndale IP Council.